
February 2024, Vol 312, No 7982
Top news stories


People harmed by valproate could receive £100,000 payout, patient safety commissioner says

Pilots to provide PrEP via pharmacies only ‘possible future opportunities’, report warns
Features

‘A mammoth undertaking’: opening the doors to Pharmacy First

Special report: has the online pharmacy bubble burst?

Changing the culture of fluoroquinolone prescribing

Everything you need to know about nitazenes
Opinion

PJ view: Private COVID-19 vaccines should be welcomed with caution

Are we self-actualising in pharmacy?

Early days of Pharmacy First highlight three things we should study

Developing a new model for cross-sector foundation training

Paul Rees: ‘Pharmacy First could be the saviour of general practice’

How credentialing assessors assure patient-focused pharmacy practice

Three core values of community pharmacy are fundamental to a healthy future
Learning & CPD

Perioperative management of type 2 diabetes mellitus

Principles of diagnostic reasoning

How pharmacists can contribute to effective antimicrobial reviews

Lithium monitoring and toxicity management

How to talk to patients about starting antidepressants

The effect of sea kelp on thyroid function in hypothyroidism

How to diagnose and manage Trichomonas vaginalis
Your RPS

RPS consults on advanced curricula for critical care and mental health pharmacy

RPS warns four out of five community pharmacy clinical lead roles could disappear when NHS funding ends

Differential attainment gap persists for black pharmacy students and trainees, says RPS report
